We are live on ! Find out more
MCM

Matarin Capital Management Portfolio holdings

AUM $409M Turnover 30.94%
1-Year Est. Return 33.03%
This Fund
S&P 500
This Quarter Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.88%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
Cap. Flow
+$34.9M
Cap. Flow %
3.23%
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47
Avg Time Held
1.1 years
Top 10 Avg Time Held
0.5 years
Top 20 Avg Time Held
0.5 years

Sector Composition

Rank Sector Weight
1 Financials 17.53%
2 Industrials 15.88%
3 Technology 13.74%
4 Consumer Discretionary 13.21%
5 Healthcare 13.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DIOD icon
151
Diodes
DIOD
$3.87B
$2.5M 0.23%
104,133
+36,831
+55% +$910K
2016 Q4
2 quarters
ENVA icon
152
Enova International
ENVA
$4.45B
$2.42M 0.22%
162,897
+17,355
+12% +$246K
2016 Q3
3 quarters
VLO icon
153
Valero Energy
VLO
$128B
$2.24M 0.21%
+33,213
New +$2.15M
2017 Q2
0 quarters
ALGN icon
154
Align Technology
ALGN
$10.5B
$2.09M 0.19%
13,916
-1,681
-11% -$228K
2015 Q4
6 quarters
IDT icon
155
IDT Corp
IDT
$2.02B
$2.09M 0.19%
171,625
-11,252
-6% -$146K
2015 Q2
8 quarters
BH icon
156
Biglari Holdings Class B
BH
$1.37B
$2.05M 0.19%
7,674
-1,404
-15% -$385K
2016 Q2
4 quarters
MSFT icon
157
Microsoft
MSFT
$3.9T
$1.96M 0.18%
28,386
+4,027
+17% +$276K
2017 Q1
1 quarter
VTRS icon
158
Viatris
VTRS
$21.2B
$1.89M 0.17%
48,683
+5,233
+12% +$201K
2017 Q1
1 quarter
LGND icon
159
Ligand Pharmaceuticals
LGND
$5.83B
$1.84M 0.17%
24,327
-39,463
-62% -$2.76M
2015 Q3
7 quarters
XHR icon
160
Xenia Hotels & Resorts
XHR
$1.75B
$1.76M 0.16%
+90,806
New +$1.66M
2017 Q2
0 quarters
EBSB
161
DELISTED
Meridian Bancorp, Inc.
EBSB
$1.76M 0.16%
103,908
+55,777
+116% +$963K
2017 Q1
1 quarter
TITN icon
162
Titan Machinery
TITN
$513M
$1.74M 0.16%
+96,610
New +$1.59M
2017 Q2
0 quarters
NXH icon
163
Neighborhood Intelligence Inc
NXH
$177M
$1.72M 0.16%
140,508
+8,201
+6% +$98.6K
2014 Q3
11 quarters
PERY
164
DELISTED
Perry Ellis International Inc
PERY
$1.68M 0.16%
86,304
+1,534
+2% +$30.1K
2014 Q3
11 quarters
AOSL icon
165
Alpha and Omega Semiconductor
AOSL
$674M
$1.65M 0.15%
99,079
-129,526
-57% -$2.3M
2016 Q2
4 quarters
MUSA icon
166
Murphy USA
MUSA
$10.1B
$1.62M 0.15%
21,802
-108,264
-83% -$7.57M
2013 Q3
15 quarters
RS icon
167
Reliance Steel & Aluminium
RS
$21B
$1.54M 0.14%
21,085
+3,220
+18% +$241K
2016 Q2
4 quarters
CTXS
168
DELISTED
Citrix Systems Inc
CTXS
$1.51M 0.14%
18,961
-24,415
-56% -$2.02M
2016 Q2
4 quarters
BRKL icon
169
DELISTED
Brookline Bancorp
BRKL
$1.47M 0.14%
100,927
-31,477
-24% -$456K
2015 Q2
8 quarters
CRAI icon
170
CRA International
CRAI
$1.11B
$1.46M 0.14%
40,322
+34,190
+558% +$1.21M
2017 Q1
1 quarter
TCBI icon
171
Texas Capital Bancshares
TCBI
$3.95B
$1.38M 0.13%
17,860
+305
+2% +$23.5K
2017 Q1
1 quarter
CFR icon
172
Cullen/Frost Bankers
CFR
$9.6B
$1.38M 0.13%
14,650
+5,982
+69% +$552K
2017 Q1
1 quarter
NFBK icon
173
DELISTED
Northfield Bancorp
NFBK
$1.37M 0.13%
79,954
-14,138
-15% -$247K
2016 Q1
5 quarters
BSET icon
174
Bassett Furniture
BSET
$187M
$1.31M 0.12%
34,607
-6,766
-16% -$203K
2016 Q3
3 quarters
LQDT icon
175
Liquidity Services
LQDT
$1.37B
$1.29M 0.12%
203,106
+1,998
+1% +$13.9K
2015 Q3
7 quarters

Similar funds

Matarin Capital Management's Q2 2017 Portfolio in Review

As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.

On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.

  • Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
  • Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
  • Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
  • Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
  • Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
  • Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
  • Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.

Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.